Home
Gruppi
Pagine
Marketplace
Mostra tutto
Gruppi Pagine Marketplace Events Blogs Funding Offers Courses
Registrati Iscriviti
Night Mode
https://www.stellarmr.com/report/US-Multiple-Sclerosis-Drugs-Market/1633
Multiple sclerosis (MS) is a chronic CNS disorder marked by demyelination and neurodegeneration. Its cause is unclear, but genetics and environmental factors contribute.
https://www.stellarmr.com/report/US-Multiple-Sclerosis-Drugs-Market/1633 Multiple sclerosis (MS) is a chronic CNS disorder marked by demyelination and neurodegeneration. Its cause is unclear, but genetics and environmental factors contribute.
www.stellarmr.com
US Multiple Sclerosis Drugs Market was valued at USD 10.74 Bn. in 2024 and is expected to reach USD 12.68 Bn. by 2032, at a CAGR of 2.1%.
0 Commenti ·0 condivisioni ·3 Views ·0 Anteprima
Effettua l'accesso per mettere mi piace, condividere e commentare!